1. |
Pharmacotherapy of anal fissure discussed |
|
Inpharma Weekly,
Volume &NA;,
Issue 1401,
2003,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
2. |
Fondaparinux sodium in orthopaedic surgery |
|
Inpharma Weekly,
Volume &NA;,
Issue 1401,
2003,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
3. |
Eletriptan economically superior to sumatriptan in migraine |
|
Inpharma Weekly,
Volume &NA;,
Issue 1401,
2003,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
4. |
Diabetic complications inflate costs in the UK, the US |
|
Inpharma Weekly,
Volume &NA;,
Issue 1401,
2003,
Page 5-6
&NA;,
Preview
|
|
摘要:
Diabetes mellitus is an increasingly prevalent condition worldwide. Costs associated with treatment of both the primary disease and its common complications are known to be substantial. Therefore, effective prevention of such complications using appropriate interventions could save considerable costs, as resource use among patients with these complications occurs both within and outside the healthcare sector. Similarly, proper management of diabetic complications when they occur could contain both direct and indirect costs. These economic issues were examined in three studies presented at the 63rd Annual Scientific Sessions of the American Diabetes Association [New Orleans, Louisiana, US; June 2003].
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
5. |
Warfarin prescribing in nonvalvular atrial fibrillation is strongly influenced by the perceived risks of warfarin use, |
|
Inpharma Weekly,
Volume &NA;,
Issue 1401,
2003,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
6. |
Retrograde delivery of IGF-1 has potential in ALS |
|
Inpharma Weekly,
Volume &NA;,
Issue 1401,
2003,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
7. |
AN 9*plus docetaxel may be safe and effective in patients with non-small-cell lung cancer, |
|
Inpharma Weekly,
Volume &NA;,
Issue 1401,
2003,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
8. |
Licofelone shows advantages over established agents in osteoarthritis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1401,
2003,
Page 9-10
RM Poole,
Preview
|
|
摘要:
Licofelone [ML 3000], a novel pyrrolizine derivative, is as effective as naproxen and celecoxib in the treatment of osteoarthritis of the knee, but has a more favourable tolerability profile, according to studies presented at the annual congress of the European League Against Rheumatism (EULAR) [Lisbon, Portugal; June 2003]. In separate studies, licofelone produced improvements in pain scores and other efficacy measures that were comparable to those achieved in patients treated with celecoxib and naproxen. However, licofelone was better tolerated, particularly with respect to gastrointestinal adverse events. The improved safety profile of licofelone may be due to its unique mechanism of action; in addition to inhibiting cyclo-oxygenase (COX)-1 and COX-2, licofelone suppresses 5-lipoxygenase (5-LOX) activity.
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
9. |
8-Bromoguanosine is effective in the treatment of experimental cutaneous leishmaniasis, |
|
Inpharma Weekly,
Volume &NA;,
Issue 1401,
2003,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
10. |
Watch and wait policy appropriate in non-Hodgkin's lymphoma |
|
Inpharma Weekly,
Volume &NA;,
Issue 1401,
2003,
Page 12-12
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|